title: Using toluidine blue as an adjunct to oral visual cancer screening among high-risk individuals may lead to increased detection of oral submucous fibrosis.
abstract: BACKGROUND
  A community-based RCT for oral cancer screening with toluidine blue. Su WW, Yen AM, Chiu SY, Chen TH. J Dent Res 2010;89(9):933-7.
  
  
  METHODS
  Mark D. Macek, DDS, DrPH PURPOSE/QUESTION: Does using toluidine blue as an adjunctive tool for oral visual cancer screening lead to higher detection rates of oral premalignant lesions among high-risk populations?
  
  
  BACKGROUND
  Information not available
  
  
  METHODS
  Randomized controlled trial
  
  
  METHODS
  Level 2: Limited-quality, patient-oriented evidence
  
  
  METHODS
  Not applicable.
authors.affiliation: Program in Health Services Research, Department of Health Promotion and Policy, University of Maryland School of Dentistry, Baltimore, Maryland 21201-1586, USA. mmacek@umaryland.edu
authors.forename: Mark D
authors.initials: MD
authors.lastname: Macek